Diabetes Knowledge in Practice

Welcome to Diabetes Knowledge in Practice, an online platform including a set of learning modules that explore theoretical and practical aspects of diabetes, including current treatment strategies, unmet needs, and future perspectives.

All educational content has been CME-accredited. Accreditation information is available before each activity.

Find out how future GLP-1 RAs will affect treatment plans

A number of novel formulations of GLP-1 receptor agonists are in development, including:

Dual GIP and GLP-1 receptor agonists

Oral formulations of GLP-1 RAs

Implantable formulations that last up to 6 months

How might these new developments indluence treatment decisions? To provide a perspective on the future of GLP-1 RA therapy, both Professor Steve Baina nd Professor Michael Nauck will be joining our next journal club on Thursday 28 February. Sign up to this free, CME-accredited webinar to reserve your slot today!

Privacy

We take your privacy seriously, please click here to view our Privacy Notice. The information above is required to help us ensure our free CME activities and learning content is suitable for your needs.

Please state that you have read and agreed to these Terms of Use before completing registration.

For further details on how your data is used and stored please read this Privacy Policy

Recover password

Please enter the email address with which you registered.

Email

Instructions on how to reset your password will be emailed to you.

CME-in-a-box

Design your own interactive meetings using a bank of CME-accredited resources

The perfect solution for busy healthcare professionals who enjoy small group learning, but can’t afford the time to plan or attend a lesson. Using this system, you can combine a number of interactive exercises to design and run your own bespoke, accredited lesson.

GLP-1 Receptor Agonists

Comprehensive guidance on the role of GLP-1 RAs in type 2 diabetes care

In the new era of individualised diabetes care, where do GLP-1 receptor agonists (RAs) fit? These interactive modules summarise international recommendations, including clinical decision-making and addressing adverse events.

Expert panel discussions

Global guidance and novel data direct from major congresses

Discover new data and clinical insights from leading international experts. Each module provides a brief summary of relevant data from a recent congress, then moves to a discussion between expert panellists.

Insulin eLearning

Cutting-edge education on insulin therapy and patient support techniques

This educational programme is designed to summarise global guidance across all levels of diabetes care. From fundamental pathophysiology to addressing post-prandial glucose, these e-learning modules will allow you to both consolidate existing knowledge and discover global guidance in managing type 1 and type 2 diabetes.

Journal clubs

Regular interactive discussions with leading experts on recent publications

These engaging, interactive discussions place you in direct contact with the authors of novel publications. Hear highlights direct from the lead authors and learn how new evidence will impact practice.

Funding information is available at the beginning of each activity. All content has been developed by Liberum IME in conjunction with an independent steering committee; financial supporters have had no influence on the content of this education.